SAB Biotherapeutics (SABS) Accumulated Depreciation (2020 - 2026)
SAB Biotherapeutics' Accumulated Depreciation was $18.75 million in Q2 2026, up 16.6% from $16.08 million a year earlier and up 3.5% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Accumulated Depreciation (2020 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Depreciation at SAB Biotherapeutics came in at $17.52 million, up 20.2% from FY2024.
- Accumulated Depreciation has now increased for five consecutive years, with a five-year compound annual growth rate of 58.2% (FY2020 to FY2025).
- In earlier years, Accumulated Depreciation was $14.57 million in FY2024 (+47.0%), $9.91 million in FY2023 (+57.9%), $6.28 million in FY2022 (+95.0%) and $3.22 million in FY2021 (+82.2%).
- The Q2 2026 figure marks the highest quarterly Accumulated Depreciation in data going back to Q4 2020.
- Compared with a year earlier, Accumulated Depreciation has increased for eight straight quarters, with growth averaging 28.9% over the last eight quarters.
- Across the past five years, year-over-year growth in Accumulated Depreciation ran from 16.6% in Q2 2026 to 95.0% in Q4 2022.
- Per Business Quant data, SABS's Accumulated Depreciation in the three quarters before Q2 2026 was $18.12 million (Q1 2026), $17.52 million (Q4 2025) and $16.82 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | SAB Biotherapeutics | 264.67 Mn | 264.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.75 Mn |
| Mar 31, 2026 | 18.12 Mn |
| Dec 31, 2025 | 17.52 Mn |
| Sep 30, 2025 | 16.82 Mn |
| Jun 30, 2025 | 16.08 Mn |
| Mar 31, 2025 | 15.32 Mn |
| Dec 31, 2024 | 14.57 Mn |
| Sep 30, 2024 | 13.85 Mn |
| Jun 30, 2024 | 12.91 Mn |
| Mar 31, 2024 | 11.87 Mn |
| Dec 31, 2023 | 9.91 Mn |
| Sep 30, 2023 | 8.99 Mn |
| Dec 31, 2022 | 6.28 Mn |
| Sep 30, 2022 | 5.38 Mn |
| Jun 30, 2022 | 4.51 Mn |
| Mar 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Dec 31, 2020 | 1.77 Mn |
API Access
SAB Biotherapeutics Accumulated Depreciation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-depreciation", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();